BioSpace News Archive

Feb. 26, 2020 13:00 UTC Personalis, Inc. to Present at Immuno-Oncology 360˚ Conference MENLO PARK, Calif.--( BUSINESS WIRE )-- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that the company will present at Immuno-Oncology 360˚ conference in New York, February 26-28. The presentation , titled “Comprehensive Immunogenomics to Enable Composite Biomarkers for Immunotherapy Response,” will describe the Personalis universal cancer imm

Leiters, a trusted FDA-registered 503B provider of high-quality compounded sterile preparations, announced its continued commitment to provide the highest quality compounded sterile preparations and pharmacy services to the healthcare market.

Employee preparedness seen on par with retailing/consumer, lagging financial services, transportation and tech

Aptorum Group Limited (NASDAQ: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today announced the pricing of a registered direct offering of 1,351,350 Class A ordinary shares and warrants to purchase 1,351,350 of its Class A ordinary shares at an exercise price of $7.40 per share.

Apixio Inc., the AI healthcare analytics company, today announced that it was among three companies selected by the National Committee for Quality Assurance (NCQA) to participate in the organization’s Natural Language Processing (NLP) Working Group.

OncLive®, the nation’s leading multimedia resource focused on providing oncology professionals with current and insightful information on patient care, will host seven State of the Science Summit™ meetings across the United States in March.

Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will present at the 40th Annual Cowen Healthcare Conference on Tuesday, March 3, 2020 at 9:20 a.m. ET, being held in Boston.

Dialectic Therapeutics, Inc., a Texas-based biotechnology company focused on creating innovative new technologies to end cancer, today announced it has received a $3 million Seed Award for Product Development Research from the Cancer Prevention & Research Institute of Texas (CPRIT)

VerdePharmHealth, a cannabis group purchasing organization (VerdePharm GPO) coupled with a clinical education & healthcare technology solutions business (VerdePharm Solutions), today announces the appointment of Robert Rosen, Dr. Ralph Boccia, and Kirill Basin to the VerdePharmHealth Board of Directors.

InsideTracker, a leading platform for personalized nutrition, has announced the launch of the new InsideTracker DNA Kit.